Geron Corporation (NASDAQ: GERN), a biopharmaceutical company at the forefront of oncology therapeutics, is garnering investor interest with its significant potential upside. With a current market capitalization of $880.46 million,..
In the ever-evolving landscape of healthcare, biotechnology companies like Upstream Bio, Inc. (NASDAQ: UPB) are attracting significant attention from investors, driven by their innovative approaches to treating complex diseases. With..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services sector, is making waves with its cutting-edge Software-as-a-Service (SaaS) solutions. Headquartered in Nashville, Tennessee, HealthStream is well-positioned to..
Inventiva S.A. – American Depositary Shares (IVA), a France-based clinical-stage biopharmaceutical company, is garnering significant attention in the biotechnology sector with its ambitious therapeutic pipeline. As a healthcare entity listed..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands out in the biotechnology sector as a clinical-stage company focused on innovative cancer treatments. With a market capitalization of $1.05 billion, ORIC is gaining..
Theravance Biopharma, Inc. (NASDAQ: TBPH), a player in the biotechnology sector, is catching the attention of investors with a notable potential upside of 30.96%. This U.S.-based company, with a market..
Zenas BioPharma, Inc. (ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is making waves in the biotechnology sector with its focus on transformative immunology-based therapies. As the company continues..
Investors seeking opportunities in the biotechnology sector may find Oruka Therapeutics, Inc. (NASDAQ: ORKA) particularly enticing. With a potential upside of 163.86% based on the average target price, Oruka is..
Iovance Biotherapeutics, Inc. (IOVA), a pioneering entity in the biotechnology sector, is attracting significant investor attention with its revolutionary approach to cancer treatment and a remarkable 313% potential upside. This..
Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, operates in the medical care facilities industry within the United States. With a current market capitalization of..
Pharvaris N.V. (PHVS), a Swiss-based biotechnology company, is making waves in the healthcare sector with its innovative approach to treating rare diseases. Specializing in the development and commercialization of therapies..
Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, is attracting considerable attention in the healthcare sector. With a market capitalization of $629.54 million, the company is dedicated to the discovery..
Trevi Therapeutics, Inc. (NASDAQ: TRVI) is a clinical-stage biopharmaceutical company that has been capturing investor attention with its promising therapeutic developments and significant growth potential. With a current market cap..
REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company, is capturing the attention of investors with a striking potential upside of 215.82%. Operating in the healthcare sector, REGENXBIO focuses on developing..
Amylyx Pharmaceuticals, Inc. (AMLX) is capturing the attention of investors eager to tap into the promising biotechnology sector. Headquartered in Cambridge, Massachusetts, Amylyx is a clinical-stage pharmaceutical company focused on..
Bioventus Inc. (NASDAQ: BVS), a healthcare company specializing in medical devices, is drawing attention for its significant potential upside as reflected in recent analyst ratings. With a market cap of..
Xencor, Inc. (NASDAQ: XNCR) stands out in the biopharmaceutical landscape, offering investors a unique opportunity in the healthcare sector. With a market capitalization of $596.97 million, this clinical-stage biotech company..
Surmodics, Inc. (NASDAQ: SRDX), a notable player in the healthcare sector with a focus on medical devices, offers a unique mix of opportunities and challenges for investors. With its headquarters..
